The oncogenic potential of WT FGFR4 is supported by the findings that FGFR4 knockdown reduced tumour growth in a human RMS cell line and lung metastases in a RMS mouse model [49], and WT FGFR4 overexpressing mouse-myoblasts induced tumour formation in vivo [81]. Here, FGFR4 is linked to neoplasm.